PRODUCTS & RD

Meta 1(A drug platform against cancer metastasis)
  The high mortality rate of cancers usually results from multi-organ failure caused by uncontrolled metastases. Therefore, the control of cancer metastatic mechanisms and the development of effective drugs are a critical issue in the R&D of anti-cancer drugs. Once the cure is developed, cancers will no longer be the leading causes of death. It is like the discovery of the Holy Grail and the pursuance of longevity is never out of reach.

Personalized and Precision Medicine



  Meta1 is an important gene involving in cancer metastasis. Metagone Biotech Inc. is developing an immune therapy to regulate Meta1 as well as filing global patents. These goals are expected to be achieved simultaneously at Q3/16.
Back to page 返回上頁